Trademark: PALYNZIQ
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for PALYNZIQ
We do not have any records of a proof of use for PALYNZIQ at this moment.
Possible trademark infringements of PALYNZIQ
Basic Information about PALYNZIQ
- Serial Number
- 87516640
- Filing Date
- 05 Jul 2017
- Registration Number
- 5576853
- Registration Date
- 02 Oct 2018
- Mark Drawing Code
- 5
Classifications
Declare the trademark use of PALYNZIQ on the blockchain with WikiTrademarks.io.
- First use of PALYNZIQ anywhere
- PALYNZIQ was first used on 02 Jul 2018 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
Who owns PALYNZIQ?
1. Biomarin Pharmaceutical Inc. Novato CA
2. Biomarin Pharmaceutical Inc. Novato CA
3. Biomarin Pharmaceutical Inc. Novato CA
Correspondent
- Gregory J. Chinlund Marshall, Gerstein & Borun LLP
- 233 South Wacker Drive, Suite 6300
- Chicago, IL 60606
- United States
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io